- SARS-CoV-2 antibodies can bind to two viral targets at once Drug Target Review
- Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression The Lancet
- Controversial new research suggests SARS-CoV-2 bears signs of genetic engineering | Mint Mint
- Tight transmission bottlenecks may limit the evolution of SARS-CoV-2 variants News-Medical.Net
- The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era The Lancet
- View Full coverage on Google News
Source: News feed
